NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients

Not Yet RecruitingPhase 4

Sponsor: Unity Health Toronto

Conditions: Cardiovascular Disease, Surgical Site Infection, Superficial Sternal Wound Infection, Mediastinitis

Interventions: Knotless Barbed Sutures, Mesh-based Topical Skin Adhesive

The goal of this clinical trial is to learn if a new method of closing the breastbone after heart bypass surgery can improve healing and reduce complications in adults undergoing coronary artery bypass graft (CABG) surgery. The main questions it aims to answer are: Does this new closure method reduce infections and wound reopening? Does it improve healing, recovery, and overall patient outcomes? Researchers will compare patients who receive the new closure method to past patients who received the standard method to see if outcomes are better. Participants will: Receive the new closure method during their surgery (as part of standard care) Be followed during their normal recovery up to their 6-week follow-up visit Complete a short quality-of-life questionnaire (about 10 minutes) Have their recovery assessed, including healing, complications, and hospital use Researchers will also look at quality of life, heart complications, hospital readmissions, antibiotic use, scar appearance, and overall costs to understand the full impact of the new method.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

\- Patients aged 18 years and older undergoing CABG surgery.

Exclusion Criteria:

* Patients who refuse to participate in the trial.
* Patients who do not read or speak English.
* Patient with allergy to surgical adhesives or sutures